Its success lies in a synergy between the technological and the clinical.
To achieve success in this market, device manufacturers should consider working with providers to help contain costs and enhance outcomes.
Medtech companies will need to collaborate more closely with other parties in healthcare, as the aftermath of the coronavirus pandemic will have a comprehensive reach throughout the entire ecosystem. MTI speaks with Johnson & Johnson VP Raymond Fryrear, M.D. on the topic.